Farxiga (Dapagliflozin Propanediol Monohydrate)

A$55.00

Farxiga (Dapagliflozin Propanediol Monohydrate) is an SGLT2 inhibitor prescribed in Australia to manage type 2 diabetes and support heart health by reducing blood sugar and cardiovascular risks.